OKYO Pharma (OKYO) News Today → This unknown company solves the biggest issue with AI (From Manward Press) (Ad) Free OKYO Stock Alerts GBX 1.40 -0.45 (-24.32%) (As of 05/19/2023) Add Compare Share Share HeadlinesStock AnalysisHeadlinesInsider TradesStock AnalysisHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 9, 2024 | americanbankingnews.comOKYO Pharma (LON:OKYO) Trading Down 24.3%May 3, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Curaleaf Holdings (OtherCURLF) and Aslan Pharmaceuticals (ASLN)March 31, 2024 | msn.comA second Kobayashi Pharma Japan factory inspected over deathsMarch 31, 2024 | msn.comJapanese authorities inspect second Kobayashi Pharma factory after deathsMarch 30, 2024 | msn.comKobayashi factory searched over deaths possibly linked to supplementsMarch 29, 2024 | msn.com5 dead and over 100 hospitalized from recalled Japanese health supplementsMarch 28, 2024 | msn.comWhat are 'beni-koji' products linked to Japan deaths?March 27, 2024 | msn.comA Japanese supplement pill is recalled after two people died and more than 100 were hospitalizedMarch 14, 2024 | msn.comUnicycive rises 4% on $50M private placementMarch 3, 2024 | msn.comPeople in Japan more worried about smell of others' excrement than their own: surveyFebruary 23, 2024 | msn.com1 in 4 Japan primary school kids with hay fever's itchy eyes have trouble studyingFebruary 22, 2024 | benzinga.comOKYO Pharma Stock (NASDAQ:OKYO), Short Interest ReportFebruary 9, 2024 | msn.comOKYO Pharma gains on receiving FDA nod of IND for OK-101 in neuropathic corneal painFebruary 9, 2024 | morningstar.comOKYO Shares Rise 12% After FDA Clearance for IND ApplicationJanuary 8, 2024 | markets.businessinsider.comOKYO Pharma Says Phase 2 Study Of OK-101 Did Not Meet Primary GoalJanuary 5, 2024 | finance.yahoo.comOKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024December 4, 2023 | proactiveinvestors.comEyepoint Pharmaceuticals stock soars on wet-AMD trial resultsDecember 4, 2023 | finance.yahoo.comOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease Has Completed Final Protocol VisitNovember 3, 2023 | msn.comHC Wainwright & Co. Initiates Coverage of OKYO Pharma Limited - (OKYO) with Buy RecommendationOctober 31, 2023 | proactiveinvestors.comOKYO Pharma raises $5.84m via share issuanceOctober 31, 2023 | finanznachrichten.deOKYO Pharma Announces $5.84 Million Cash Raise and Payables ReductionOctober 5, 2023 | msn.comDry Eye Disease Affects Around 50M Americans, OKYO Pharma's Candidate Shows Safety In Mid-Stage StudyOctober 5, 2023 | msn.comOKYO shares retreat 12% after rallying ahead of Phase 2 study updateOctober 5, 2023 | markets.businessinsider.comOKYO Pharma Reports Positive Safety Data Profile For OK-101 In Dry Eye DiseaseOctober 5, 2023 | proactiveinvestors.comOKYO Pharma phase II dry eye trial making encouraging progressOctober 5, 2023 | finance.yahoo.comOKYO Pharma Announces Positive Safety Data Profile for the ongoing OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease ("DED")September 15, 2023 | proactiveinvestors.comOKYO Pharma closes $4M registered direct offeringSeptember 14, 2023 | finance.yahoo.comOKYO Pharma Announces Pricing of $4.0 Million Registered Direct Offering of Ordinary SharesAugust 30, 2023 | uk.finance.yahoo.comOKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2 Clinical Trial of OK-101 to treat Dry Eye Disease (“DED”)August 29, 2023 | proactiveinvestors.comOKYO Pharma regains compliance with Nasdaq listing minimum...OKYO Pharma regains compliance with Nasdaq listing minimum market...August 29, 2023 | marketwatch.comOKYO Pharma Shares Rise 15% After Regaining Nasdaq ComplianceAugust 1, 2023 | proactiveinvestors.comOKYO Pharma withdraws public offerJuly 28, 2023 | marketwatch.comStocks to Watch: Barnes & Noble Education, HomeStreet and OKYO PharmaJuly 28, 2023 | finance.yahoo.comOKYO Pharma Limited Receives Nasdaq Deficiency NoticeJuly 28, 2023 | finance.yahoo.comOKYO Pharma Announces Proposed Public Offering of Ordinary SharesMay 30, 2023 | benzinga.comEye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?May 11, 2023 | finanznachrichten.deOKYO Pharma LTD: OKYO Pharma Now Participating on the Webull Corporate Communications Service PlatformMay 11, 2023 | finance.yahoo.comOKYO Pharma Now Participating on the Webull Corporate Communications Service PlatformMay 9, 2023 | finance.yahoo.comGoldman Small Cap Research Publishes New Research Report on OKYO Pharma LimitedMay 2, 2023 | proactiveinvestors.comOKYO Pharma reaches milestone with first patient screening for dry eye disease trialMay 2, 2023 | proactiveinvestors.comOKYO Pharma screens first patient for dry eye disease trialMay 2, 2023 | finance.yahoo.comOKYO Pharma Announces First-Patient First-Visit for Phase 2 Trial Evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye DiseaseApril 29, 2023 | ca.finance.yahoo.comOKYO Pharma Limited (OKYO)April 26, 2023 | benzinga.comOKYO Pharma Activates First Clinical Trial Site For Phase 2 Study Of OK-101 To Treat Dry Eye DiseaseApril 18, 2023 | msn.comLondon stock market is 'a complete waste of time': Italian biotech tycoon plans to quit the CityApril 18, 2023 | benzinga.comOKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred PayApril 4, 2023 | reuters.comFTSE 100 falls as oil stocks drag, pound risesApril 4, 2023 | finanznachrichten.deOKYO Pharma LTD: Notice of Intention to Delist From The London Stock ExchangeApril 4, 2023 | marketwatch.comOkyo Pharma Shares Fall on London Stock Delisting PlanApril 4, 2023 | proactiveinvestors.comOKYO Pharma plans UK de-listing in favour of US quote Get OKYO Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter. Email Address A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. OKYO Media Mentions By Week OKYO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OKYO News Sentiment▼0.000.55▲Average Medical News Sentiment OKYO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OKYO Articles This Week▼10▲OKYO Articles Average Week Get OKYO Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Hemogenyx Pharmaceuticals News Today Sareum News Today Oncimmune News Today OptiBiotix Health News Today C4X Discovery News Today Destiny Pharma News Today Ondine Biomedical News Today Synairgen News Today BiVictriX Therapeutics News Today ImmuPharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OKYO) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OKYO Pharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
